Switzerland · Investor

Debiopharm Group

Last cheque observed Mar 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

SeedSeries ASeries BHealth CareLife ScienceRobotics

Cheques on record
0%of best year0cheques in 12 months, 10 on record
Since the last cheque4618days00hrs00min00sec
Median round$11MRounds led0 of 10Sole investor3 roundsMostly inSwitzerland, 70%
Pitch Debiopharm Group

Debiopharm Group highlights

  1. 01

    10 rounds on record

  2. 02

    Mostly Series A and Venture: 56% of its rounds

  3. 03

    Sole investor in 3 rounds, median $6.0M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
Health CareLife ScienceRobotics
Based in
Lausanne, Switzerland
Cold pitches
Not stated

The record

Every round we can evidence, newest first10 appearances

  1. 2014

    1 round

  2. Mar
    ImmunexpressVenture · US$6.0MSole investor
  3. 2013

    3 rounds

  4. Sept
    KeyLemonSeries A · CH · techcrunch.com$1.5MWith 1 other
  5. May
    urturnSeries A · CH · techcrunch.com$13MWith 1 other
  6. Jan
    SpinomixSeries A · CH · finsmes.com$3.0MSole investor
  7. 2012

    3 rounds

  8. Dec
    BiocartisSeries D · CH$45MWith 4 others
  9. Nov
    SkiooSeed · CH$1.3MWith 1 other
  10. May
    AgendiaGrowth · NL · bizjournals.com$65MWith 4 others
  11. 2011

    1 round

  12. Nov
    BiocartisSeries C · CH · finsmes.com$96MWith 2 others
  13. 2010

    2 rounds

  14. Apr
    BiocartisSeries B · CH · biocartis.com$40MWith 4 others
  15. Feb
    CurisVenture · US · fiercebiotech.com$8.0MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Companies it bought

Acquisitions by the firm itself

Affinium PharmaceuticalsUndisclosedFeb 2014

Who they invest alongside

The investors most often in the same rounds as Debiopharm Group. A count of rooms they were both in, not a relationship either has claimed.

Johnson & Johnson Development Corporation (JJDC)VC firm3rounds together

Quick answers about Debiopharm Group

What does Debiopharm Group invest in?

Debiopharm Group invests most often at Series A and Venture (56% of the rounds on record), in sectors such as Health Care, Life Science and Robotics.

How active is Debiopharm Group?

10 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2014.

How big are Debiopharm Group's cheques?

The median round it joins is $11M.

Does Debiopharm Group lead rounds?

Rarely, if at all: none of its 10 investments on record names it as the lead.

Where does Debiopharm Group invest?

Most of the companies it backs are in Switzerland (70%), the United States (20%) and the Netherlands (10%).

Is Debiopharm Group investing now?

No investments in the last 12 months; the latest was in Mar 2014.

Who does Debiopharm Group invest alongside?

Most often Johnson & Johnson Development Corporation (JJDC) (3 rounds together).

What kind of investor is Debiopharm Group?

Debiopharm Group is a VC firm based in Lausanne, Switzerland.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it